CRBP
Price
$4.92
Change
-$0.28 (-5.38%)
Updated
Apr 3 closing price
Capitalization
60.18M
FBIO
Price
$1.52
Change
-$0.09 (-5.59%)
Updated
Apr 3 closing price
Capitalization
41.96M
Ad is loading...

CRBP vs FBIO

Header iconCRBP vs FBIO Comparison
Open Charts CRBP vs FBIOBanner chart's image
Corbus Pharmaceuticals Holdings
Price$4.92
Change-$0.28 (-5.38%)
Volume$224.82K
Capitalization60.18M
Fortress Biotech
Price$1.52
Change-$0.09 (-5.59%)
Volume$230.59K
Capitalization41.96M
CRBP vs FBIO Comparison Chart
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. FBIO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a Hold and FBIO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CRBP: $4.92 vs. FBIO: $1.52)
Brand notoriety: CRBP and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 90% vs. FBIO: 73%
Market capitalization -- CRBP: $60.18M vs. FBIO: $41.96M
CRBP [@Biotechnology] is valued at $60.18M. FBIO’s [@Biotechnology] market capitalization is $41.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileFBIO’s FA Score has 0 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • FBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIO is a better buy in the long-term than CRBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish while FBIO’s TA Score has 4 bullish TA indicator(s).

  • CRBP’s TA Score: 5 bullish, 3 bearish.
  • FBIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRBP is a better buy in the short-term than FBIO.

Price Growth

CRBP (@Biotechnology) experienced а -15.03% price change this week, while FBIO (@Biotechnology) price change was -12.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

CRBP is expected to report earnings on May 11, 2023.

FBIO is expected to report earnings on Mar 27, 2024.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($60.2M) has a higher market cap than FBIO($42M). FBIO YTD gains are higher at: -24.938 vs. CRBP (-58.305). CRBP has higher annual earnings (EBITDA): -37.75M vs. FBIO (-108.52M). CRBP has more cash in the bank: 149M vs. FBIO (58.9M). CRBP has less debt than FBIO: CRBP (3.24M) vs FBIO (71.5M). FBIO has higher revenues than CRBP: FBIO (62.5M) vs CRBP (0).
CRBPFBIOCRBP / FBIO
Capitalization60.2M42M143%
EBITDA-37.75M-108.52M35%
Gain YTD-58.305-24.938234%
P/E RatioN/AN/A-
Revenue062.5M-
Total Cash149M58.9M253%
Total Debt3.24M71.5M5%
FUNDAMENTALS RATINGS
CRBP vs FBIO: Fundamental Ratings
CRBP
FBIO
OUTLOOK RATING
1..100
6521
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9660
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (33) in the Biotechnology industry is in the same range as CRBP (55). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRBP (100). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

CRBP's SMR Rating (98) in the Biotechnology industry is in the same range as FBIO (100). This means that CRBP’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for CRBP (96). This means that FBIO’s stock grew somewhat faster than CRBP’s over the last 12 months.

FBIO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRBP (100). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRBPFBIO
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAIC114.26-1.44
-1.24%
Science Applications International Corp
JD39.90-1.19
-2.90%
JD.com
ASRV2.37-0.08
-3.27%
AmeriServ Financial
WLFC151.59-8.98
-5.59%
Willis Lease Finance Corp
ADV1.31-0.14
-9.66%
Advantage Solutions

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-5.38%
SKYE - CRBP
41%
Loosely correlated
-2.10%
APLS - CRBP
36%
Loosely correlated
-2.09%
FBIO - CRBP
36%
Loosely correlated
-5.59%
PMCB - CRBP
31%
Poorly correlated
-4.62%
STOK - CRBP
29%
Poorly correlated
-4.55%
More

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-5.59%
AXON - FBIO
38%
Loosely correlated
-3.35%
CRBP - FBIO
37%
Loosely correlated
-5.38%
ABOS - FBIO
35%
Loosely correlated
-8.52%
QSI - FBIO
32%
Poorly correlated
-5.69%
AVIR - FBIO
32%
Poorly correlated
+0.69%
More